Track topics on Twitter Track topics that are important to you
New Investment to Fuel New Product Innovations and Strategic Growth
SAN DIEGO (PRWEB) March 26, 2019
Confirm BioSciences, the San Diego, CA-based leader for high-quality diagnostic testing and health & wellness solutions for both the corporate community and individual consumers, today announced it has secured impact financing from HCAP Partners, a California-based private equity firm and recognized impact investor.
Confirm BioSciences has made a great impact on corporate and personal wellness with its instant and lab-based testing solutions, educational resources, and straightforward results reports for concerns ranging from drugs of abuse to health and well-being. The testing tools are utilized by over 10,000 business customers and sold to consumers directly at many major retailers and online at https://testcountry.com and https://livewelltesting.com
Launched in 2008, Confirm BioSciences has been recognized among the fastest-growing in the U.S., scaling over 2000% as one of the top private companies providing drugs of abuse and health & wellness testing, and yielding a yearly growth rate of over 30%. The Company, which donates 5% of its profits to homeless shelters, has also earned a spot among Inc.’s 2018 Best Workplaces and in San Diego Business Journal’s Best Places to Work four times, ranking #1 in 2016 and 2017, for its missionary ethos approach to the workplace.
“From the start, our mission has been to help create drug-free homes, workplaces, and environments,” said Zeynep Ilgaz, Co-founder and CEO of Confirm BioSciences. “We continue to accomplish this by providing quality products, raising awareness of the issues, and supporting our communities. This partnership with HCAP Partners will provide us with additional strategic value, and help us further our mission and scale our business to impact even more geographies worldwide.”
The Company is currently poised for immense growth with channel expansion, including the recent launch of HairConfirm® (http://www.hairconfirm.com) in the retail market, upcoming new products serving the corporate customer and individual consumers alike, as well as international market expansion.
“We see tremendous opportunity for Confirm BioSciences' continued growth and are thrilled to partner with this dynamic team,” said Tim Bubnack, Managing Partner at HCAP Partners. “The company has built strong momentum in the market and its core guiding principles of employee focus and nurturing meaningful jobs align directly with HCAP’s impact focus and Gainful Jobs Approach™."
For more information on Confirm BioSciences, its product portfolio, and leadership team, please visit http://www.confirmbiosciences.com.
About Confirm BioSciences
Confirm BioSciences is a pioneer in high-quality diagnostic testing and health & wellness solutions for both the corporate community and individual consumers. Our product portfolio ranges from instant and lab-based testing solutions for drugs of abuse, including HairConfirm® (hair-based) and Drug Confirm® (urine-based), to HealthConfirm®, a line of testing solutions for health & wellness hormones and neurotransmitters, with all results delivered in user-friendly reports. As experts in the drug testing and health & wellness markets, Confirm BioSciences prides ourselves in supporting various organizations and projects that help families create a drug-free home. Confirm BioSciences is headquartered in San Diego, California. For company information, visit http://www.confirmbiosciences.com.
About HCAP Partners
HCAP Partners was founded in 2000 and is a provider of mezzanine debt and private equity for underserved, lower-middle market companies throughout California and the Western United States. The firm seeks to invest $2 million to $10 million in established businesses generating between $10 million and $75 million in revenues in the healthcare, software, services, and manufacturing industries. HCAP Partners has invested in over 60 companies since it was founded and through ongoing, active engagement with portfolio companies the team at HCAP Partners provides value-added resources to help optimize performance and increase enterprise value. The firm has been recognized as an ImpactAssets 50 fund six years running and, through its Gainful Jobs Approach™, works to facilitate a positive impact on underserved businesses, their employees, and their communities through active portfolio engagement. Partners Tim Bubnack and Frank Mora and Principals Hope Mago and Nicolas Lopez lead HCAP Partners’ investment team. For more information, please visit http://www.hcapllc.com.
For the original version on PRWeb visit: https://www.prweb.com/releases/confirm_biosciences_secures_funding_with_hcap_partners_to_accelerate_global_expansion/prweb16192155.htmNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...